Publications by authors named "Juana V Barrera"
Article Synopsis
- Hepatocellular carcinoma (HCC) is a major cause of cancer deaths, with better prognoses in early stages; transarterial radioembolization (TARE) offers a safer alternative treatment option, especially in advanced cases.
- The study evaluated how certain biomarkers—related to liver function and immune response—might predict tumor response to Y90 TARE among HCC patients.
- Results from 35 patients showed that 51% responded favorably to treatment, with notable predictive biomarkers being an ALBI score of ≤-2.8 and a low neutrophil-to-lymphocyte ratio, both indicating higher odds of a positive response.
